Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xtampza ER for Pain Management in Head and Neck Cancer Radiotherapy
NCT03317730Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of oxycodone DETERx in pain, sponsored by University of Alabama at Birmingham. Primary endpoint: Feasibility of Xtampza ER during radiotherapy at 1 year. Started May 2018; status: completed.
02
Drugs
oxycodone DETERx
03
Conditions
pain
Beyond the preview
Go deeper on NCT03317730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317730.